- Report
- October 2026
- 160 Pages
Global
From €3066EUR$3,320USD£2,565GBP
€3833EUR$4,150USD£3,206GBP
- Report
- June 2024
- 76 Pages
Global
From €1293EUR$1,400USD£1,082GBP
- Report
- February 2025
- 100 Pages
Global
From €5496EUR$5,950USD£4,597GBP
- Report
- June 2025
- 110 Pages
Global
From €4526EUR$4,900USD£3,785GBP
- Report
- March 2022
- 55 Pages
Global
From €1847EUR$2,000USD£1,545GBP
€3695EUR$4,000USD£3,090GBP
- Report
- September 2026
- 150 Pages
Indonesia
From €4387EUR$4,750USD£3,670GBP
- Report
- March 2026
- 150 Pages
China
From €4480EUR$4,850USD£3,747GBP
- Report
- March 2026
- 150 Pages
Germany
From €4480EUR$4,850USD£3,747GBP
- Report
- March 2026
- 150 Pages
India
From €4480EUR$4,850USD£3,747GBP
- Report
- July 2025
- 150 Pages
Global
From €4480EUR$4,850USD£3,747GBP
- Report
- September 2025
- 79 Pages
Global
From €3500EUR$4,059USD£3,030GBP
- Report
- March 2024
- 84 Pages
Global
From €3500EUR$4,059USD£3,030GBP
- Report
- March 2022
- 98 Pages
Global
From €3500EUR$4,059USD£3,030GBP

Plasma Medicine is a field of healthcare services that focuses on the use of plasma-based therapies to treat a variety of medical conditions. Plasma is the liquid component of blood, and it contains proteins, antibodies, and other molecules that can be used to treat a variety of diseases. Plasma-based therapies are used to treat conditions such as cancer, autoimmune diseases, and genetic disorders. Plasma-based therapies can also be used to treat infections, wounds, and burns.
Plasma Medicine is a rapidly growing field of healthcare services, with new treatments and technologies being developed to improve patient outcomes. Plasma-based therapies are often used in combination with other treatments, such as chemotherapy and radiation therapy, to provide a more comprehensive approach to patient care.
Some companies in the Plasma Medicine market include Grifols, CSL Behring, Octapharma, Kedrion, and Biotest. Show Less Read more